Minority Health Archive

Disentangling the effects of race on breast cancer treatment

Banerjee, Mousumi and George, Julie and Yee, Cecilia and Hryniuk, William and Schwartz, Kendra (2007) Disentangling the effects of race on breast cancer treatment. Cancer, 110 (10). pp. 2169-2177. ISSN 0008543X

Full text not available from this repository.


BACKGROUND. African Americans (AA) have higher mortality from breast cancer compared with white Americans (WA). Studies using population-based cancer registries have attributed this to disparities in treatment after normalizing the AA and WA populations for differences in disease stage. However, those studies were hampered by lack of comorbidity data and limited information about systemic treatments. The objective of the current study was to investigate racial disparities in breast cancer treatment by conducting a comprehensive medical records review of women who were diagnosed with breast cancer at the Karmanos Cancer Institute (KCI) in Detroit, Michigan. METHODS. The study cohort consisted of 651 women who were diagnosed with primary breast cancer between 1990 and 1996 at KCI. Multivariable logistic regression analysis controlling for sociodemographic factors, tumor characteristics, comorbidities, and health insurance status was used to assess whether there were differences between WA and AA in the receipt of breast-conserving surgery (BCS), radiation, tamoxifen, and chemotherapy. RESULTS. There was no significant difference between WA and AA in the receipt of BCS versus mastectomy. Patients with local-stage disease who were enrolled in government insurance plans underwent mastectomy more often (vs BCS plus radiation) compared with patients who were enrolled in nongovernment plans. The rates of receipt of tamoxifen and chemotherapy were similar for local-stage WA and local-stage AA. However, WA were more likely to receive tamoxifen and/or chemotherapy for regional-stage disease. Married women with regional disease were more likely to receive chemotherapy than nonmarried women. CONCLUSIONS. The results from this study may be used to target educational interventions to improve the use of adjuvant therapies among AA women who have regional-stage disease. Cancer 2007 © 2007 American Cancer Society.

Export/Citation:EndNote | BibTeX | Dublin Core | ASCII (Chicago style) | HTML Citation | OpenURL | Reference Manager
Social Networking:

Item Type: Article
Additional Information: This article is available at the publisher’s Web site. Access to the full text is subject to the publisher’s access restrictions.
Uncontrolled Keywords: racial disparity;treatment;breast cancer;comorbidity;health insurance
Subjects: Health > Disparities
Health > Public Health > Chronic Illness & Diseases > Cancer
Research > studies
Related URLs:
Depositing User: Users 141 not found.
Date Deposited: 30 Jul 2011 15:58
Last Modified: 30 Jul 2011 15:58
Link to this item (URI): http://health-equity.lib.umd.edu/id/eprint/2930

Actions (login required)

View Item